NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email A number of companies have found themselves facing questions about their work with Immigration and Customs Enforcement amid the agency’s intense operation in Minnesota.Read More